We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Elan, Eisai To Pay $214M Over Zonegran Marketing

Law360 (December 16, 2010, 1:56 PM EST) -- The U.S. government has finalized a $203.5 million criminal and civil settlement with Irish drugmaker Elan Corp. PLC over off-label marketing of epilepsy drug Zonegran, as well as revealed an $11...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.